Eric Lefkofsky’s Tempus to Major on Data in Their Battle Against Cancer
Tempus is a Chicago-based startup by Eric Lefkofsky that aims at gathering relevant information about cancer patients and processing it. They believe it goes a long way in helping the cancer specialists as they continue improving the treatment. Recently the foundation registered an interest in sharing their data with the University of Chicago doctors, so as to assist them in curing against breast cancer.Their primary goal is to help the medics in doing molecular sequencing, and some day in the future give results that are reliable and clearer, and hence be able to prescribe improved medication on their patients. Chicago Medicine acknowledged Tempus’ efforts and confessed it was great partnering with them. A professor of human medicine and genetics said that often the doctors have to treat patients without information on their genes, which will now be resolved, courtesy of the partnership with Tempus.
Important Things About Eric and his Endeavors at Tempus
Before founding Tempus where he works as the CEO, Eric had worked in other organizations providing healthcare-related services. At Tempus, they developed an operating system aimed at fighting cancer. He ensures involvement of many doctors from across the world. They analyze the data and brainstorm on essentials that could guide them in improving treatment for their patients. Tempus is the big thing to watch.
The Eric’s Acts of Kindness
Lefkofsky Family Foundation is an organization through which the couple supports people from within the community. It is privately held and has crucial roles to play in their community involvement. Additionally, Eric is a Trustee of Chicago’s Lurie Children’s Hospital, The Art Institute, World Business Chicago as well as the Museum of Science and Industry. He also has several other influential administrative positions in other charitable foundations.
The alumnus of University of Michigan, Law School is an amazing figure with unstoppable zeal. He and his wife, Elizabeth channel so much of their fortune towards cancer-related research. With Tempus, which has already hit the road on the right note, no doubt there are great things to expect. The foundation is projected to grow to levels of dealing with all cancer cases.